Global Autoimmunity Reagents Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Autoimmunity Reagents market size is predicted to grow from US$ 1563 million in 2025 to US$ 2671 million in 2031; it is expected to grow at a CAGR of 9.3% from 2025 to 2031.
Autoimmune diseases refer to diseases caused by the body's immune response to self-antigens, resulting in damage to its own tissues. Common autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus and vasculitis.
According to the regional perspective, the market of Autoimmunity Reagents can be divided into North America, Europe, Japan, China, etc. in 2019, the market share of Europe is the highest, accounting for about 43%, of which the Asia Pacific region is the main growth pole of the commodity consumption.
EUROIMMUN?HUMAN?Bio-Rad Laboratories are the key manufacturers in the Global Autoimmunity Reagents Production Market. Top 3 totally took up nearly 50% of the global market in 2019, among which EUROIMMUN is the leader with a market share of over 29%.
LP Information, Inc. (LPI) ' newest research report, the “Autoimmunity Reagents Industry Forecast” looks at past sales and reviews total world Autoimmunity Reagents sales in 2024, providing a comprehensive analysis by region and market sector of projected Autoimmunity Reagents sales for 2025 through 2031. With Autoimmunity Reagents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autoimmunity Reagents industry.
This Insight Report provides a comprehensive analysis of the global Autoimmunity Reagents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Autoimmunity Reagents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Autoimmunity Reagents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autoimmunity Reagents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autoimmunity Reagents.
This report presents a comprehensive overview, market shares, and growth opportunities of Autoimmunity Reagents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Autoimmunity Reagents market?
What factors are driving Autoimmunity Reagents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Autoimmunity Reagents market opportunities vary by end market size?
How does Autoimmunity Reagents break out by Type, by Application?
The global Autoimmunity Reagents market size is predicted to grow from US$ 1563 million in 2025 to US$ 2671 million in 2031; it is expected to grow at a CAGR of 9.3% from 2025 to 2031.
Autoimmune diseases refer to diseases caused by the body's immune response to self-antigens, resulting in damage to its own tissues. Common autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus and vasculitis.
According to the regional perspective, the market of Autoimmunity Reagents can be divided into North America, Europe, Japan, China, etc. in 2019, the market share of Europe is the highest, accounting for about 43%, of which the Asia Pacific region is the main growth pole of the commodity consumption.
EUROIMMUN?HUMAN?Bio-Rad Laboratories are the key manufacturers in the Global Autoimmunity Reagents Production Market. Top 3 totally took up nearly 50% of the global market in 2019, among which EUROIMMUN is the leader with a market share of over 29%.
LP Information, Inc. (LPI) ' newest research report, the “Autoimmunity Reagents Industry Forecast” looks at past sales and reviews total world Autoimmunity Reagents sales in 2024, providing a comprehensive analysis by region and market sector of projected Autoimmunity Reagents sales for 2025 through 2031. With Autoimmunity Reagents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autoimmunity Reagents industry.
This Insight Report provides a comprehensive analysis of the global Autoimmunity Reagents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Autoimmunity Reagents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Autoimmunity Reagents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autoimmunity Reagents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autoimmunity Reagents.
This report presents a comprehensive overview, market shares, and growth opportunities of Autoimmunity Reagents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- BLOT
- ELISA
- IFA
- CLIA
- Hospital
- Third-Party Testing Agency
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- EUROIMMUN
- HUMAN
- Bio-Rad Laboratories
- AESKU
- Inova
- MBL
- Orgentec
- Trinity
- Phadia
- HOB Biotech
- Shenzhen YHLO Biotech
- Kangrun Biotech
- Immuno-Biological Laboratories
- Biomedical diagnostics
- Shanghai Kexin
What is the 10-year outlook for the global Autoimmunity Reagents market?
What factors are driving Autoimmunity Reagents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Autoimmunity Reagents market opportunities vary by end market size?
How does Autoimmunity Reagents break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Autoimmunity Reagents Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Autoimmunity Reagents by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Autoimmunity Reagents by Country/Region, 2020, 2024 & 2031
2.2 Autoimmunity Reagents Segment by Type
2.2.1 BLOT
2.2.2 ELISA
2.2.3 IFA
2.2.4 CLIA
2.3 Autoimmunity Reagents Sales by Type
2.3.1 Global Autoimmunity Reagents Sales Market Share by Type (2020-2025)
2.3.2 Global Autoimmunity Reagents Revenue and Market Share by Type (2020-2025)
2.3.3 Global Autoimmunity Reagents Sale Price by Type (2020-2025)
2.4 Autoimmunity Reagents Segment by Application
2.4.1 Hospital
2.4.2 Third-Party Testing Agency
2.5 Autoimmunity Reagents Sales by Application
2.5.1 Global Autoimmunity Reagents Sale Market Share by Application (2020-2025)
2.5.2 Global Autoimmunity Reagents Revenue and Market Share by Application (2020-2025)
2.5.3 Global Autoimmunity Reagents Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Autoimmunity Reagents Breakdown Data by Company
3.1.1 Global Autoimmunity Reagents Annual Sales by Company (2020-2025)
3.1.2 Global Autoimmunity Reagents Sales Market Share by Company (2020-2025)
3.2 Global Autoimmunity Reagents Annual Revenue by Company (2020-2025)
3.2.1 Global Autoimmunity Reagents Revenue by Company (2020-2025)
3.2.2 Global Autoimmunity Reagents Revenue Market Share by Company (2020-2025)
3.3 Global Autoimmunity Reagents Sale Price by Company
3.4 Key Manufacturers Autoimmunity Reagents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Autoimmunity Reagents Product Location Distribution
3.4.2 Players Autoimmunity Reagents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AUTOIMMUNITY REAGENTS BY GEOGRAPHIC REGION
4.1 World Historic Autoimmunity Reagents Market Size by Geographic Region (2020-2025)
4.1.1 Global Autoimmunity Reagents Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Autoimmunity Reagents Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Autoimmunity Reagents Market Size by Country/Region (2020-2025)
4.2.1 Global Autoimmunity Reagents Annual Sales by Country/Region (2020-2025)
4.2.2 Global Autoimmunity Reagents Annual Revenue by Country/Region (2020-2025)
4.3 Americas Autoimmunity Reagents Sales Growth
4.4 APAC Autoimmunity Reagents Sales Growth
4.5 Europe Autoimmunity Reagents Sales Growth
4.6 Middle East & Africa Autoimmunity Reagents Sales Growth
5 AMERICAS
5.1 Americas Autoimmunity Reagents Sales by Country
5.1.1 Americas Autoimmunity Reagents Sales by Country (2020-2025)
5.1.2 Americas Autoimmunity Reagents Revenue by Country (2020-2025)
5.2 Americas Autoimmunity Reagents Sales by Type (2020-2025)
5.3 Americas Autoimmunity Reagents Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Autoimmunity Reagents Sales by Region
6.1.1 APAC Autoimmunity Reagents Sales by Region (2020-2025)
6.1.2 APAC Autoimmunity Reagents Revenue by Region (2020-2025)
6.2 APAC Autoimmunity Reagents Sales by Type (2020-2025)
6.3 APAC Autoimmunity Reagents Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Autoimmunity Reagents by Country
7.1.1 Europe Autoimmunity Reagents Sales by Country (2020-2025)
7.1.2 Europe Autoimmunity Reagents Revenue by Country (2020-2025)
7.2 Europe Autoimmunity Reagents Sales by Type (2020-2025)
7.3 Europe Autoimmunity Reagents Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Autoimmunity Reagents by Country
8.1.1 Middle East & Africa Autoimmunity Reagents Sales by Country (2020-2025)
8.1.2 Middle East & Africa Autoimmunity Reagents Revenue by Country (2020-2025)
8.2 Middle East & Africa Autoimmunity Reagents Sales by Type (2020-2025)
8.3 Middle East & Africa Autoimmunity Reagents Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Autoimmunity Reagents
10.3 Manufacturing Process Analysis of Autoimmunity Reagents
10.4 Industry Chain Structure of Autoimmunity Reagents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Autoimmunity Reagents Distributors
11.3 Autoimmunity Reagents Customer
12 WORLD FORECAST REVIEW FOR AUTOIMMUNITY REAGENTS BY GEOGRAPHIC REGION
12.1 Global Autoimmunity Reagents Market Size Forecast by Region
12.1.1 Global Autoimmunity Reagents Forecast by Region (2026-2031)
12.1.2 Global Autoimmunity Reagents Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Autoimmunity Reagents Forecast by Type (2026-2031)
12.7 Global Autoimmunity Reagents Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 EUROIMMUN
13.1.1 EUROIMMUN Company Information
13.1.2 EUROIMMUN Autoimmunity Reagents Product Portfolios and Specifications
13.1.3 EUROIMMUN Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 EUROIMMUN Main Business Overview
13.1.5 EUROIMMUN Latest Developments
13.2 HUMAN
13.2.1 HUMAN Company Information
13.2.2 HUMAN Autoimmunity Reagents Product Portfolios and Specifications
13.2.3 HUMAN Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 HUMAN Main Business Overview
13.2.5 HUMAN Latest Developments
13.3 Bio-Rad Laboratories
13.3.1 Bio-Rad Laboratories Company Information
13.3.2 Bio-Rad Laboratories Autoimmunity Reagents Product Portfolios and Specifications
13.3.3 Bio-Rad Laboratories Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bio-Rad Laboratories Main Business Overview
13.3.5 Bio-Rad Laboratories Latest Developments
13.4 AESKU
13.4.1 AESKU Company Information
13.4.2 AESKU Autoimmunity Reagents Product Portfolios and Specifications
13.4.3 AESKU Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AESKU Main Business Overview
13.4.5 AESKU Latest Developments
13.5 Inova
13.5.1 Inova Company Information
13.5.2 Inova Autoimmunity Reagents Product Portfolios and Specifications
13.5.3 Inova Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Inova Main Business Overview
13.5.5 Inova Latest Developments
13.6 MBL
13.6.1 MBL Company Information
13.6.2 MBL Autoimmunity Reagents Product Portfolios and Specifications
13.6.3 MBL Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 MBL Main Business Overview
13.6.5 MBL Latest Developments
13.7 Orgentec
13.7.1 Orgentec Company Information
13.7.2 Orgentec Autoimmunity Reagents Product Portfolios and Specifications
13.7.3 Orgentec Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Orgentec Main Business Overview
13.7.5 Orgentec Latest Developments
13.8 Trinity
13.8.1 Trinity Company Information
13.8.2 Trinity Autoimmunity Reagents Product Portfolios and Specifications
13.8.3 Trinity Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Trinity Main Business Overview
13.8.5 Trinity Latest Developments
13.9 Phadia
13.9.1 Phadia Company Information
13.9.2 Phadia Autoimmunity Reagents Product Portfolios and Specifications
13.9.3 Phadia Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Phadia Main Business Overview
13.9.5 Phadia Latest Developments
13.10 HOB Biotech
13.10.1 HOB Biotech Company Information
13.10.2 HOB Biotech Autoimmunity Reagents Product Portfolios and Specifications
13.10.3 HOB Biotech Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 HOB Biotech Main Business Overview
13.10.5 HOB Biotech Latest Developments
13.11 Shenzhen YHLO Biotech
13.11.1 Shenzhen YHLO Biotech Company Information
13.11.2 Shenzhen YHLO Biotech Autoimmunity Reagents Product Portfolios and Specifications
13.11.3 Shenzhen YHLO Biotech Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Shenzhen YHLO Biotech Main Business Overview
13.11.5 Shenzhen YHLO Biotech Latest Developments
13.12 Kangrun Biotech
13.12.1 Kangrun Biotech Company Information
13.12.2 Kangrun Biotech Autoimmunity Reagents Product Portfolios and Specifications
13.12.3 Kangrun Biotech Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Kangrun Biotech Main Business Overview
13.12.5 Kangrun Biotech Latest Developments
13.13 Immuno-Biological Laboratories
13.13.1 Immuno-Biological Laboratories Company Information
13.13.2 Immuno-Biological Laboratories Autoimmunity Reagents Product Portfolios and Specifications
13.13.3 Immuno-Biological Laboratories Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Immuno-Biological Laboratories Main Business Overview
13.13.5 Immuno-Biological Laboratories Latest Developments
13.14 Biomedical diagnostics
13.14.1 Biomedical diagnostics Company Information
13.14.2 Biomedical diagnostics Autoimmunity Reagents Product Portfolios and Specifications
13.14.3 Biomedical diagnostics Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Biomedical diagnostics Main Business Overview
13.14.5 Biomedical diagnostics Latest Developments
13.15 Shanghai Kexin
13.15.1 Shanghai Kexin Company Information
13.15.2 Shanghai Kexin Autoimmunity Reagents Product Portfolios and Specifications
13.15.3 Shanghai Kexin Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Shanghai Kexin Main Business Overview
13.15.5 Shanghai Kexin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Autoimmunity Reagents Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Autoimmunity Reagents Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of BLOT
Table 4. Major Players of ELISA
Table 5. Major Players of IFA
Table 6. Major Players of CLIA
Table 7. Global Autoimmunity Reagents Sales byType (2020-2025) & (K Unit)
Table 8. Global Autoimmunity Reagents Sales Market Share byType (2020-2025)
Table 9. Global Autoimmunity Reagents Revenue byType (2020-2025) & ($ million)
Table 10. Global Autoimmunity Reagents Revenue Market Share byType (2020-2025)
Table 11. Global Autoimmunity Reagents Sale Price byType (2020-2025) & (USD/Unit)
Table 12. Global Autoimmunity Reagents Sale by Application (2020-2025) & (K Unit)
Table 13. Global Autoimmunity Reagents Sale Market Share by Application (2020-2025)
Table 14. Global Autoimmunity Reagents Revenue by Application (2020-2025) & ($ million)
Table 15. Global Autoimmunity Reagents Revenue Market Share by Application (2020-2025)
Table 16. Global Autoimmunity Reagents Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Autoimmunity Reagents Sales by Company (2020-2025) & (K Unit)
Table 18. Global Autoimmunity Reagents Sales Market Share by Company (2020-2025)
Table 19. Global Autoimmunity Reagents Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Autoimmunity Reagents Revenue Market Share by Company (2020-2025)
Table 21. Global Autoimmunity Reagents Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Autoimmunity Reagents Producing Area Distribution and Sales Area
Table 23. Players Autoimmunity Reagents Products Offered
Table 24. Autoimmunity Reagents Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Autoimmunity Reagents Sales by Geographic Region (2020-2025) & (K Unit)
Table 28. Global Autoimmunity Reagents Sales Market Share Geographic Region (2020-2025)
Table 29. Global Autoimmunity Reagents Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Autoimmunity Reagents Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Autoimmunity Reagents Sales by Country/Region (2020-2025) & (K Unit)
Table 32. Global Autoimmunity Reagents Sales Market Share by Country/Region (2020-2025)
Table 33. Global Autoimmunity Reagents Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Autoimmunity Reagents Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Autoimmunity Reagents Sales by Country (2020-2025) & (K Unit)
Table 36. Americas Autoimmunity Reagents Sales Market Share by Country (2020-2025)
Table 37. Americas Autoimmunity Reagents Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Autoimmunity Reagents Sales byType (2020-2025) & (K Unit)
Table 39. Americas Autoimmunity Reagents Sales by Application (2020-2025) & (K Unit)
Table 40. APAC Autoimmunity Reagents Sales by Region (2020-2025) & (K Unit)
Table 41. APAC Autoimmunity Reagents Sales Market Share by Region (2020-2025)
Table 42. APAC Autoimmunity Reagents Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Autoimmunity Reagents Sales byType (2020-2025) & (K Unit)
Table 44. APAC Autoimmunity Reagents Sales by Application (2020-2025) & (K Unit)
Table 45. Europe Autoimmunity Reagents Sales by Country (2020-2025) & (K Unit)
Table 46. Europe Autoimmunity Reagents Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Autoimmunity Reagents Sales byType (2020-2025) & (K Unit)
Table 48. Europe Autoimmunity Reagents Sales by Application (2020-2025) & (K Unit)
Table 49. Middle East & Africa Autoimmunity Reagents Sales by Country (2020-2025) & (K Unit)
Table 50. Middle East & Africa Autoimmunity Reagents Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Autoimmunity Reagents Sales byType (2020-2025) & (K Unit)
Table 52. Middle East & Africa Autoimmunity Reagents Sales by Application (2020-2025) & (K Unit)
Table 53. Key Market Drivers & Growth Opportunities of Autoimmunity Reagents
Table 54. Key Market Challenges & Risks of Autoimmunity Reagents
Table 55. Key IndustryTrends of Autoimmunity Reagents
Table 56. Autoimmunity Reagents Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Autoimmunity Reagents Distributors List
Table 59. Autoimmunity Reagents Customer List
Table 60. Global Autoimmunity Reagents SalesForecast by Region (2026-2031) & (K Unit)
Table 61. Global Autoimmunity Reagents RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Autoimmunity Reagents SalesForecast by Country (2026-2031) & (K Unit)
Table 63. Americas Autoimmunity Reagents Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Autoimmunity Reagents SalesForecast by Region (2026-2031) & (K Unit)
Table 65. APAC Autoimmunity Reagents Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Autoimmunity Reagents SalesForecast by Country (2026-2031) & (K Unit)
Table 67. Europe Autoimmunity Reagents RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Autoimmunity Reagents SalesForecast by Country (2026-2031) & (K Unit)
Table 69. Middle East & Africa Autoimmunity Reagents RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Autoimmunity Reagents SalesForecast byType (2026-2031) & (K Unit)
Table 71. Global Autoimmunity Reagents RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Autoimmunity Reagents SalesForecast by Application (2026-2031) & (K Unit)
Table 73. Global Autoimmunity Reagents RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. EUROIMMUN Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 75. EUROIMMUN Autoimmunity Reagents Product Portfolios and Specifications
Table 76. EUROIMMUN Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. EUROIMMUN Main Business
Table 78. EUROIMMUN Latest Developments
Table 79. HUMAN Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 80. HUMAN Autoimmunity Reagents Product Portfolios and Specifications
Table 81. HUMAN Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. HUMAN Main Business
Table 83. HUMAN Latest Developments
Table 84. Bio-Rad Laboratories Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 85. Bio-Rad Laboratories Autoimmunity Reagents Product Portfolios and Specifications
Table 86. Bio-Rad Laboratories Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Bio-Rad Laboratories Main Business
Table 88. Bio-Rad Laboratories Latest Developments
Table 89. AESKU Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 90. AESKU Autoimmunity Reagents Product Portfolios and Specifications
Table 91. AESKU Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. AESKU Main Business
Table 93. AESKU Latest Developments
Table 94. Inova Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 95. Inova Autoimmunity Reagents Product Portfolios and Specifications
Table 96. Inova Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Inova Main Business
Table 98. Inova Latest Developments
Table 99. MBL Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 100. MBL Autoimmunity Reagents Product Portfolios and Specifications
Table 101. MBL Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. MBL Main Business
Table 103. MBL Latest Developments
Table 104. Orgentec Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 105. Orgentec Autoimmunity Reagents Product Portfolios and Specifications
Table 106. Orgentec Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Orgentec Main Business
Table 108. Orgentec Latest Developments
Table 109.Trinity Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 110.Trinity Autoimmunity Reagents Product Portfolios and Specifications
Table 111.Trinity Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112.Trinity Main Business
Table 113.Trinity Latest Developments
Table 114. Phadia Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 115. Phadia Autoimmunity Reagents Product Portfolios and Specifications
Table 116. Phadia Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Phadia Main Business
Table 118. Phadia Latest Developments
Table 119. HOB Biotech Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 120. HOB Biotech Autoimmunity Reagents Product Portfolios and Specifications
Table 121. HOB Biotech Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. HOB Biotech Main Business
Table 123. HOB Biotech Latest Developments
Table 124. Shenzhen YHLO Biotech Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 125. Shenzhen YHLO Biotech Autoimmunity Reagents Product Portfolios and Specifications
Table 126. Shenzhen YHLO Biotech Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Shenzhen YHLO Biotech Main Business
Table 128. Shenzhen YHLO Biotech Latest Developments
Table 129. Kangrun Biotech Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 130. Kangrun Biotech Autoimmunity Reagents Product Portfolios and Specifications
Table 131. Kangrun Biotech Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Kangrun Biotech Main Business
Table 133. Kangrun Biotech Latest Developments
Table 134. Immuno-Biological Laboratories Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 135. Immuno-Biological Laboratories Autoimmunity Reagents Product Portfolios and Specifications
Table 136. Immuno-Biological Laboratories Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Immuno-Biological Laboratories Main Business
Table 138. Immuno-Biological Laboratories Latest Developments
Table 139. Biomedical diagnostics Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 140. Biomedical diagnostics Autoimmunity Reagents Product Portfolios and Specifications
Table 141. Biomedical diagnostics Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Biomedical diagnostics Main Business
Table 143. Biomedical diagnostics Latest Developments
Table 144. Shanghai Kexin Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 145. Shanghai Kexin Autoimmunity Reagents Product Portfolios and Specifications
Table 146. Shanghai Kexin Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Shanghai Kexin Main Business
Table 148. Shanghai Kexin Latest Developments
LIST OFFIGURES
Figure 1. Picture of Autoimmunity Reagents
Figure 2. Autoimmunity Reagents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Autoimmunity Reagents Sales Growth Rate 2020-2031 (K Unit)
Figure 7. Global Autoimmunity Reagents Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Autoimmunity Reagents Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Autoimmunity Reagents Sales Market Share by Country/Region (2024)
Figure 10. Autoimmunity Reagents Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of BLOT
Figure 12. Product Picture of ELISA
Figure 13. Product Picture of IFA
Figure 14. Product Picture of CLIA
Figure 15. Global Autoimmunity Reagents Sales Market Share byType in 2025
Figure 16. Global Autoimmunity Reagents Revenue Market Share byType (2020-2025)
Figure 17. Autoimmunity Reagents Consumed in Hospital
Figure 18. Global Autoimmunity Reagents Market: Hospital (2020-2025) & (K Unit)
Figure 19. Autoimmunity Reagents Consumed inThird-PartyTesting Agency
Figure 20. Global Autoimmunity Reagents Market:Third-PartyTesting Agency (2020-2025) & (K Unit)
Figure 21. Global Autoimmunity Reagents Sale Market Share by Application (2024)
Figure 22. Global Autoimmunity Reagents Revenue Market Share by Application in 2025
Figure 23. Autoimmunity Reagents Sales by Company in 2025 (K Unit)
Figure 24. Global Autoimmunity Reagents Sales Market Share by Company in 2025
Figure 25. Autoimmunity Reagents Revenue by Company in 2025 ($ millions)
Figure 26. Global Autoimmunity Reagents Revenue Market Share by Company in 2025
Figure 27. Global Autoimmunity Reagents Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Autoimmunity Reagents Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Autoimmunity Reagents Sales 2020-2025 (K Unit)
Figure 30. Americas Autoimmunity Reagents Revenue 2020-2025 ($ millions)
Figure 31. APAC Autoimmunity Reagents Sales 2020-2025 (K Unit)
Figure 32. APAC Autoimmunity Reagents Revenue 2020-2025 ($ millions)
Figure 33. Europe Autoimmunity Reagents Sales 2020-2025 (K Unit)
Figure 34. Europe Autoimmunity Reagents Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Autoimmunity Reagents Sales 2020-2025 (K Unit)
Figure 36. Middle East & Africa Autoimmunity Reagents Revenue 2020-2025 ($ millions)
Figure 37. Americas Autoimmunity Reagents Sales Market Share by Country in 2025
Figure 38. Americas Autoimmunity Reagents Revenue Market Share by Country (2020-2025)
Figure 39. Americas Autoimmunity Reagents Sales Market Share byType (2020-2025)
Figure 40. Americas Autoimmunity Reagents Sales Market Share by Application (2020-2025)
Figure 41. United States Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Autoimmunity Reagents Sales Market Share by Region in 2025
Figure 46. APAC Autoimmunity Reagents Revenue Market Share by Region (2020-2025)
Figure 47. APAC Autoimmunity Reagents Sales Market Share byType (2020-2025)
Figure 48. APAC Autoimmunity Reagents Sales Market Share by Application (2020-2025)
Figure 49. China Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 53. India Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Autoimmunity Reagents Sales Market Share by Country in 2025
Figure 57. Europe Autoimmunity Reagents Revenue Market Share by Country (2020-2025)
Figure 58. Europe Autoimmunity Reagents Sales Market Share byType (2020-2025)
Figure 59. Europe Autoimmunity Reagents Sales Market Share by Application (2020-2025)
Figure 60. Germany Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 61.France Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Autoimmunity Reagents Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Autoimmunity Reagents Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Autoimmunity Reagents Sales Market Share by Application (2020-2025)
Figure 68. Egypt Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Autoimmunity Reagents in 2025
Figure 74. Manufacturing Process Analysis of Autoimmunity Reagents
Figure 75. Industry Chain Structure of Autoimmunity Reagents
Figure 76. Channels of Distribution
Figure 77. Global Autoimmunity Reagents Sales MarketForecast by Region (2026-2031)
Figure 78. Global Autoimmunity Reagents Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Autoimmunity Reagents Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Autoimmunity Reagents Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Autoimmunity Reagents Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Autoimmunity Reagents Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Autoimmunity Reagents Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Autoimmunity Reagents by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Autoimmunity Reagents by Country/Region, 2020, 2024 & 2031
2.2 Autoimmunity Reagents Segment by Type
2.2.1 BLOT
2.2.2 ELISA
2.2.3 IFA
2.2.4 CLIA
2.3 Autoimmunity Reagents Sales by Type
2.3.1 Global Autoimmunity Reagents Sales Market Share by Type (2020-2025)
2.3.2 Global Autoimmunity Reagents Revenue and Market Share by Type (2020-2025)
2.3.3 Global Autoimmunity Reagents Sale Price by Type (2020-2025)
2.4 Autoimmunity Reagents Segment by Application
2.4.1 Hospital
2.4.2 Third-Party Testing Agency
2.5 Autoimmunity Reagents Sales by Application
2.5.1 Global Autoimmunity Reagents Sale Market Share by Application (2020-2025)
2.5.2 Global Autoimmunity Reagents Revenue and Market Share by Application (2020-2025)
2.5.3 Global Autoimmunity Reagents Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Autoimmunity Reagents Breakdown Data by Company
3.1.1 Global Autoimmunity Reagents Annual Sales by Company (2020-2025)
3.1.2 Global Autoimmunity Reagents Sales Market Share by Company (2020-2025)
3.2 Global Autoimmunity Reagents Annual Revenue by Company (2020-2025)
3.2.1 Global Autoimmunity Reagents Revenue by Company (2020-2025)
3.2.2 Global Autoimmunity Reagents Revenue Market Share by Company (2020-2025)
3.3 Global Autoimmunity Reagents Sale Price by Company
3.4 Key Manufacturers Autoimmunity Reagents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Autoimmunity Reagents Product Location Distribution
3.4.2 Players Autoimmunity Reagents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AUTOIMMUNITY REAGENTS BY GEOGRAPHIC REGION
4.1 World Historic Autoimmunity Reagents Market Size by Geographic Region (2020-2025)
4.1.1 Global Autoimmunity Reagents Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Autoimmunity Reagents Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Autoimmunity Reagents Market Size by Country/Region (2020-2025)
4.2.1 Global Autoimmunity Reagents Annual Sales by Country/Region (2020-2025)
4.2.2 Global Autoimmunity Reagents Annual Revenue by Country/Region (2020-2025)
4.3 Americas Autoimmunity Reagents Sales Growth
4.4 APAC Autoimmunity Reagents Sales Growth
4.5 Europe Autoimmunity Reagents Sales Growth
4.6 Middle East & Africa Autoimmunity Reagents Sales Growth
5 AMERICAS
5.1 Americas Autoimmunity Reagents Sales by Country
5.1.1 Americas Autoimmunity Reagents Sales by Country (2020-2025)
5.1.2 Americas Autoimmunity Reagents Revenue by Country (2020-2025)
5.2 Americas Autoimmunity Reagents Sales by Type (2020-2025)
5.3 Americas Autoimmunity Reagents Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Autoimmunity Reagents Sales by Region
6.1.1 APAC Autoimmunity Reagents Sales by Region (2020-2025)
6.1.2 APAC Autoimmunity Reagents Revenue by Region (2020-2025)
6.2 APAC Autoimmunity Reagents Sales by Type (2020-2025)
6.3 APAC Autoimmunity Reagents Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Autoimmunity Reagents by Country
7.1.1 Europe Autoimmunity Reagents Sales by Country (2020-2025)
7.1.2 Europe Autoimmunity Reagents Revenue by Country (2020-2025)
7.2 Europe Autoimmunity Reagents Sales by Type (2020-2025)
7.3 Europe Autoimmunity Reagents Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Autoimmunity Reagents by Country
8.1.1 Middle East & Africa Autoimmunity Reagents Sales by Country (2020-2025)
8.1.2 Middle East & Africa Autoimmunity Reagents Revenue by Country (2020-2025)
8.2 Middle East & Africa Autoimmunity Reagents Sales by Type (2020-2025)
8.3 Middle East & Africa Autoimmunity Reagents Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Autoimmunity Reagents
10.3 Manufacturing Process Analysis of Autoimmunity Reagents
10.4 Industry Chain Structure of Autoimmunity Reagents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Autoimmunity Reagents Distributors
11.3 Autoimmunity Reagents Customer
12 WORLD FORECAST REVIEW FOR AUTOIMMUNITY REAGENTS BY GEOGRAPHIC REGION
12.1 Global Autoimmunity Reagents Market Size Forecast by Region
12.1.1 Global Autoimmunity Reagents Forecast by Region (2026-2031)
12.1.2 Global Autoimmunity Reagents Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Autoimmunity Reagents Forecast by Type (2026-2031)
12.7 Global Autoimmunity Reagents Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 EUROIMMUN
13.1.1 EUROIMMUN Company Information
13.1.2 EUROIMMUN Autoimmunity Reagents Product Portfolios and Specifications
13.1.3 EUROIMMUN Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 EUROIMMUN Main Business Overview
13.1.5 EUROIMMUN Latest Developments
13.2 HUMAN
13.2.1 HUMAN Company Information
13.2.2 HUMAN Autoimmunity Reagents Product Portfolios and Specifications
13.2.3 HUMAN Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 HUMAN Main Business Overview
13.2.5 HUMAN Latest Developments
13.3 Bio-Rad Laboratories
13.3.1 Bio-Rad Laboratories Company Information
13.3.2 Bio-Rad Laboratories Autoimmunity Reagents Product Portfolios and Specifications
13.3.3 Bio-Rad Laboratories Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bio-Rad Laboratories Main Business Overview
13.3.5 Bio-Rad Laboratories Latest Developments
13.4 AESKU
13.4.1 AESKU Company Information
13.4.2 AESKU Autoimmunity Reagents Product Portfolios and Specifications
13.4.3 AESKU Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AESKU Main Business Overview
13.4.5 AESKU Latest Developments
13.5 Inova
13.5.1 Inova Company Information
13.5.2 Inova Autoimmunity Reagents Product Portfolios and Specifications
13.5.3 Inova Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Inova Main Business Overview
13.5.5 Inova Latest Developments
13.6 MBL
13.6.1 MBL Company Information
13.6.2 MBL Autoimmunity Reagents Product Portfolios and Specifications
13.6.3 MBL Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 MBL Main Business Overview
13.6.5 MBL Latest Developments
13.7 Orgentec
13.7.1 Orgentec Company Information
13.7.2 Orgentec Autoimmunity Reagents Product Portfolios and Specifications
13.7.3 Orgentec Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Orgentec Main Business Overview
13.7.5 Orgentec Latest Developments
13.8 Trinity
13.8.1 Trinity Company Information
13.8.2 Trinity Autoimmunity Reagents Product Portfolios and Specifications
13.8.3 Trinity Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Trinity Main Business Overview
13.8.5 Trinity Latest Developments
13.9 Phadia
13.9.1 Phadia Company Information
13.9.2 Phadia Autoimmunity Reagents Product Portfolios and Specifications
13.9.3 Phadia Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Phadia Main Business Overview
13.9.5 Phadia Latest Developments
13.10 HOB Biotech
13.10.1 HOB Biotech Company Information
13.10.2 HOB Biotech Autoimmunity Reagents Product Portfolios and Specifications
13.10.3 HOB Biotech Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 HOB Biotech Main Business Overview
13.10.5 HOB Biotech Latest Developments
13.11 Shenzhen YHLO Biotech
13.11.1 Shenzhen YHLO Biotech Company Information
13.11.2 Shenzhen YHLO Biotech Autoimmunity Reagents Product Portfolios and Specifications
13.11.3 Shenzhen YHLO Biotech Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Shenzhen YHLO Biotech Main Business Overview
13.11.5 Shenzhen YHLO Biotech Latest Developments
13.12 Kangrun Biotech
13.12.1 Kangrun Biotech Company Information
13.12.2 Kangrun Biotech Autoimmunity Reagents Product Portfolios and Specifications
13.12.3 Kangrun Biotech Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Kangrun Biotech Main Business Overview
13.12.5 Kangrun Biotech Latest Developments
13.13 Immuno-Biological Laboratories
13.13.1 Immuno-Biological Laboratories Company Information
13.13.2 Immuno-Biological Laboratories Autoimmunity Reagents Product Portfolios and Specifications
13.13.3 Immuno-Biological Laboratories Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Immuno-Biological Laboratories Main Business Overview
13.13.5 Immuno-Biological Laboratories Latest Developments
13.14 Biomedical diagnostics
13.14.1 Biomedical diagnostics Company Information
13.14.2 Biomedical diagnostics Autoimmunity Reagents Product Portfolios and Specifications
13.14.3 Biomedical diagnostics Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Biomedical diagnostics Main Business Overview
13.14.5 Biomedical diagnostics Latest Developments
13.15 Shanghai Kexin
13.15.1 Shanghai Kexin Company Information
13.15.2 Shanghai Kexin Autoimmunity Reagents Product Portfolios and Specifications
13.15.3 Shanghai Kexin Autoimmunity Reagents Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Shanghai Kexin Main Business Overview
13.15.5 Shanghai Kexin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Autoimmunity Reagents Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Autoimmunity Reagents Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of BLOT
Table 4. Major Players of ELISA
Table 5. Major Players of IFA
Table 6. Major Players of CLIA
Table 7. Global Autoimmunity Reagents Sales byType (2020-2025) & (K Unit)
Table 8. Global Autoimmunity Reagents Sales Market Share byType (2020-2025)
Table 9. Global Autoimmunity Reagents Revenue byType (2020-2025) & ($ million)
Table 10. Global Autoimmunity Reagents Revenue Market Share byType (2020-2025)
Table 11. Global Autoimmunity Reagents Sale Price byType (2020-2025) & (USD/Unit)
Table 12. Global Autoimmunity Reagents Sale by Application (2020-2025) & (K Unit)
Table 13. Global Autoimmunity Reagents Sale Market Share by Application (2020-2025)
Table 14. Global Autoimmunity Reagents Revenue by Application (2020-2025) & ($ million)
Table 15. Global Autoimmunity Reagents Revenue Market Share by Application (2020-2025)
Table 16. Global Autoimmunity Reagents Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Autoimmunity Reagents Sales by Company (2020-2025) & (K Unit)
Table 18. Global Autoimmunity Reagents Sales Market Share by Company (2020-2025)
Table 19. Global Autoimmunity Reagents Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Autoimmunity Reagents Revenue Market Share by Company (2020-2025)
Table 21. Global Autoimmunity Reagents Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Autoimmunity Reagents Producing Area Distribution and Sales Area
Table 23. Players Autoimmunity Reagents Products Offered
Table 24. Autoimmunity Reagents Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Autoimmunity Reagents Sales by Geographic Region (2020-2025) & (K Unit)
Table 28. Global Autoimmunity Reagents Sales Market Share Geographic Region (2020-2025)
Table 29. Global Autoimmunity Reagents Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Autoimmunity Reagents Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Autoimmunity Reagents Sales by Country/Region (2020-2025) & (K Unit)
Table 32. Global Autoimmunity Reagents Sales Market Share by Country/Region (2020-2025)
Table 33. Global Autoimmunity Reagents Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Autoimmunity Reagents Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Autoimmunity Reagents Sales by Country (2020-2025) & (K Unit)
Table 36. Americas Autoimmunity Reagents Sales Market Share by Country (2020-2025)
Table 37. Americas Autoimmunity Reagents Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Autoimmunity Reagents Sales byType (2020-2025) & (K Unit)
Table 39. Americas Autoimmunity Reagents Sales by Application (2020-2025) & (K Unit)
Table 40. APAC Autoimmunity Reagents Sales by Region (2020-2025) & (K Unit)
Table 41. APAC Autoimmunity Reagents Sales Market Share by Region (2020-2025)
Table 42. APAC Autoimmunity Reagents Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Autoimmunity Reagents Sales byType (2020-2025) & (K Unit)
Table 44. APAC Autoimmunity Reagents Sales by Application (2020-2025) & (K Unit)
Table 45. Europe Autoimmunity Reagents Sales by Country (2020-2025) & (K Unit)
Table 46. Europe Autoimmunity Reagents Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Autoimmunity Reagents Sales byType (2020-2025) & (K Unit)
Table 48. Europe Autoimmunity Reagents Sales by Application (2020-2025) & (K Unit)
Table 49. Middle East & Africa Autoimmunity Reagents Sales by Country (2020-2025) & (K Unit)
Table 50. Middle East & Africa Autoimmunity Reagents Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Autoimmunity Reagents Sales byType (2020-2025) & (K Unit)
Table 52. Middle East & Africa Autoimmunity Reagents Sales by Application (2020-2025) & (K Unit)
Table 53. Key Market Drivers & Growth Opportunities of Autoimmunity Reagents
Table 54. Key Market Challenges & Risks of Autoimmunity Reagents
Table 55. Key IndustryTrends of Autoimmunity Reagents
Table 56. Autoimmunity Reagents Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Autoimmunity Reagents Distributors List
Table 59. Autoimmunity Reagents Customer List
Table 60. Global Autoimmunity Reagents SalesForecast by Region (2026-2031) & (K Unit)
Table 61. Global Autoimmunity Reagents RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Autoimmunity Reagents SalesForecast by Country (2026-2031) & (K Unit)
Table 63. Americas Autoimmunity Reagents Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Autoimmunity Reagents SalesForecast by Region (2026-2031) & (K Unit)
Table 65. APAC Autoimmunity Reagents Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Autoimmunity Reagents SalesForecast by Country (2026-2031) & (K Unit)
Table 67. Europe Autoimmunity Reagents RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Autoimmunity Reagents SalesForecast by Country (2026-2031) & (K Unit)
Table 69. Middle East & Africa Autoimmunity Reagents RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Autoimmunity Reagents SalesForecast byType (2026-2031) & (K Unit)
Table 71. Global Autoimmunity Reagents RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Autoimmunity Reagents SalesForecast by Application (2026-2031) & (K Unit)
Table 73. Global Autoimmunity Reagents RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. EUROIMMUN Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 75. EUROIMMUN Autoimmunity Reagents Product Portfolios and Specifications
Table 76. EUROIMMUN Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. EUROIMMUN Main Business
Table 78. EUROIMMUN Latest Developments
Table 79. HUMAN Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 80. HUMAN Autoimmunity Reagents Product Portfolios and Specifications
Table 81. HUMAN Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. HUMAN Main Business
Table 83. HUMAN Latest Developments
Table 84. Bio-Rad Laboratories Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 85. Bio-Rad Laboratories Autoimmunity Reagents Product Portfolios and Specifications
Table 86. Bio-Rad Laboratories Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Bio-Rad Laboratories Main Business
Table 88. Bio-Rad Laboratories Latest Developments
Table 89. AESKU Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 90. AESKU Autoimmunity Reagents Product Portfolios and Specifications
Table 91. AESKU Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. AESKU Main Business
Table 93. AESKU Latest Developments
Table 94. Inova Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 95. Inova Autoimmunity Reagents Product Portfolios and Specifications
Table 96. Inova Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Inova Main Business
Table 98. Inova Latest Developments
Table 99. MBL Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 100. MBL Autoimmunity Reagents Product Portfolios and Specifications
Table 101. MBL Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. MBL Main Business
Table 103. MBL Latest Developments
Table 104. Orgentec Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 105. Orgentec Autoimmunity Reagents Product Portfolios and Specifications
Table 106. Orgentec Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Orgentec Main Business
Table 108. Orgentec Latest Developments
Table 109.Trinity Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 110.Trinity Autoimmunity Reagents Product Portfolios and Specifications
Table 111.Trinity Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112.Trinity Main Business
Table 113.Trinity Latest Developments
Table 114. Phadia Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 115. Phadia Autoimmunity Reagents Product Portfolios and Specifications
Table 116. Phadia Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Phadia Main Business
Table 118. Phadia Latest Developments
Table 119. HOB Biotech Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 120. HOB Biotech Autoimmunity Reagents Product Portfolios and Specifications
Table 121. HOB Biotech Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. HOB Biotech Main Business
Table 123. HOB Biotech Latest Developments
Table 124. Shenzhen YHLO Biotech Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 125. Shenzhen YHLO Biotech Autoimmunity Reagents Product Portfolios and Specifications
Table 126. Shenzhen YHLO Biotech Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Shenzhen YHLO Biotech Main Business
Table 128. Shenzhen YHLO Biotech Latest Developments
Table 129. Kangrun Biotech Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 130. Kangrun Biotech Autoimmunity Reagents Product Portfolios and Specifications
Table 131. Kangrun Biotech Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Kangrun Biotech Main Business
Table 133. Kangrun Biotech Latest Developments
Table 134. Immuno-Biological Laboratories Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 135. Immuno-Biological Laboratories Autoimmunity Reagents Product Portfolios and Specifications
Table 136. Immuno-Biological Laboratories Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Immuno-Biological Laboratories Main Business
Table 138. Immuno-Biological Laboratories Latest Developments
Table 139. Biomedical diagnostics Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 140. Biomedical diagnostics Autoimmunity Reagents Product Portfolios and Specifications
Table 141. Biomedical diagnostics Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Biomedical diagnostics Main Business
Table 143. Biomedical diagnostics Latest Developments
Table 144. Shanghai Kexin Basic Information, Autoimmunity Reagents Manufacturing Base, Sales Area and Its Competitors
Table 145. Shanghai Kexin Autoimmunity Reagents Product Portfolios and Specifications
Table 146. Shanghai Kexin Autoimmunity Reagents Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Shanghai Kexin Main Business
Table 148. Shanghai Kexin Latest Developments
LIST OFFIGURES
Figure 1. Picture of Autoimmunity Reagents
Figure 2. Autoimmunity Reagents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Autoimmunity Reagents Sales Growth Rate 2020-2031 (K Unit)
Figure 7. Global Autoimmunity Reagents Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Autoimmunity Reagents Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Autoimmunity Reagents Sales Market Share by Country/Region (2024)
Figure 10. Autoimmunity Reagents Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of BLOT
Figure 12. Product Picture of ELISA
Figure 13. Product Picture of IFA
Figure 14. Product Picture of CLIA
Figure 15. Global Autoimmunity Reagents Sales Market Share byType in 2025
Figure 16. Global Autoimmunity Reagents Revenue Market Share byType (2020-2025)
Figure 17. Autoimmunity Reagents Consumed in Hospital
Figure 18. Global Autoimmunity Reagents Market: Hospital (2020-2025) & (K Unit)
Figure 19. Autoimmunity Reagents Consumed inThird-PartyTesting Agency
Figure 20. Global Autoimmunity Reagents Market:Third-PartyTesting Agency (2020-2025) & (K Unit)
Figure 21. Global Autoimmunity Reagents Sale Market Share by Application (2024)
Figure 22. Global Autoimmunity Reagents Revenue Market Share by Application in 2025
Figure 23. Autoimmunity Reagents Sales by Company in 2025 (K Unit)
Figure 24. Global Autoimmunity Reagents Sales Market Share by Company in 2025
Figure 25. Autoimmunity Reagents Revenue by Company in 2025 ($ millions)
Figure 26. Global Autoimmunity Reagents Revenue Market Share by Company in 2025
Figure 27. Global Autoimmunity Reagents Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Autoimmunity Reagents Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Autoimmunity Reagents Sales 2020-2025 (K Unit)
Figure 30. Americas Autoimmunity Reagents Revenue 2020-2025 ($ millions)
Figure 31. APAC Autoimmunity Reagents Sales 2020-2025 (K Unit)
Figure 32. APAC Autoimmunity Reagents Revenue 2020-2025 ($ millions)
Figure 33. Europe Autoimmunity Reagents Sales 2020-2025 (K Unit)
Figure 34. Europe Autoimmunity Reagents Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Autoimmunity Reagents Sales 2020-2025 (K Unit)
Figure 36. Middle East & Africa Autoimmunity Reagents Revenue 2020-2025 ($ millions)
Figure 37. Americas Autoimmunity Reagents Sales Market Share by Country in 2025
Figure 38. Americas Autoimmunity Reagents Revenue Market Share by Country (2020-2025)
Figure 39. Americas Autoimmunity Reagents Sales Market Share byType (2020-2025)
Figure 40. Americas Autoimmunity Reagents Sales Market Share by Application (2020-2025)
Figure 41. United States Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Autoimmunity Reagents Sales Market Share by Region in 2025
Figure 46. APAC Autoimmunity Reagents Revenue Market Share by Region (2020-2025)
Figure 47. APAC Autoimmunity Reagents Sales Market Share byType (2020-2025)
Figure 48. APAC Autoimmunity Reagents Sales Market Share by Application (2020-2025)
Figure 49. China Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 53. India Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Autoimmunity Reagents Sales Market Share by Country in 2025
Figure 57. Europe Autoimmunity Reagents Revenue Market Share by Country (2020-2025)
Figure 58. Europe Autoimmunity Reagents Sales Market Share byType (2020-2025)
Figure 59. Europe Autoimmunity Reagents Sales Market Share by Application (2020-2025)
Figure 60. Germany Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 61.France Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Autoimmunity Reagents Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Autoimmunity Reagents Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Autoimmunity Reagents Sales Market Share by Application (2020-2025)
Figure 68. Egypt Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Autoimmunity Reagents Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Autoimmunity Reagents in 2025
Figure 74. Manufacturing Process Analysis of Autoimmunity Reagents
Figure 75. Industry Chain Structure of Autoimmunity Reagents
Figure 76. Channels of Distribution
Figure 77. Global Autoimmunity Reagents Sales MarketForecast by Region (2026-2031)
Figure 78. Global Autoimmunity Reagents Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Autoimmunity Reagents Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Autoimmunity Reagents Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Autoimmunity Reagents Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Autoimmunity Reagents Revenue Market ShareForecast by Application (2026-2031)
